Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25...

Descripción completa

Detalles Bibliográficos
Autores principales: Rondy, Marc, Kissling, Esther, Emborg, Hanne-Dorthe, Gherasim, Alin, Pebody, Richard, Trebbien, Ramona, Pozo, Francisco, Larrauri, Amparo, McMenamin, Jim, Valenciano, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2018
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840921/
https://www.ncbi.nlm.nih.gov/pubmed/29510782
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840921/
https://www.ncbi.nlm.nih.gov/pubmed/29510782
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086

Ejemplares similares